Côd QR

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study

Abstract Background Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg has been shown to improve lung function and health status, and reduce exacerbations, versus budesonide/formoterol in patients with chronic obstructive pulmonary disease (COPD). We evaluated the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Peter R. Bremner, Ruby Birk, Noushin Brealey, Afisi S. Ismaila, Chang-Qing Zhu, David A. Lipson
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMC 2018-01-01
Cyfres:Respiratory Research
Pynciau:
COPD
Exacerbations
FEV1
Lung function
Fluticasone furoate/umeclidinium/vilanterol
Randomized controlled trial
Mynediad Ar-lein:http://link.springer.com/article/10.1186/s12931-018-0724-0
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg